Therapeutics Development NOFOs
- PAR-22-200: Development of medications to prevent and treat opioids/psychostimulant use dis and overdose (UG3/UH3)
- PAR-22-202: Grand opportunity in medications development to treat substance use disorders (U01)
- PAR-22-182: Behavioral & integrative treatment development program (R01)
- PAR-22-183: Behavioral & integrative treatment development program (R34)
- PAR-21-183: Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3)
- PAR-20-279 Device-Based Treatments for Substance Use Disorders (UG3/UH3)